Akebia Therapeutics, Inc. (AKBA)

Typically moves ±12.69% on earnings

EARNINGS ANALYTICS

event_note Approx. Next Earnings: ~2026-11-06 APPROXIMATE

Akebia Therapeutics, Inc. (AKBA) has a 22-report earnings history dating back to May 10, 2021. Its average absolute post-earnings move is ±12.69%, and 31.8% of those reactions were positive. Its largest post-earnings gain was +24.09% (Mar 14, 2024) and its largest decline was -26.05% (Aug 05, 2026). The next earnings report is predicted for 2026-11-06 (approximate).

Earnings reactions

How AKBA moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±12.69%

Positive %

31.8%

Negative %

68.2%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
Aug 05, 2026	☽ POST	-26.05%	open_in_new
May 07, 2026	☀ PRE	-20.2%	open_in_new
Feb 26, 2026	☀ PRE	+9.09%	open_in_new
Nov 10, 2025	☀ PRE	-18.14%	open_in_new
Aug 07, 2025	☀ PRE	-20.48%	open_in_new
May 08, 2025	☀ PRE	+6.5%	open_in_new
Mar 13, 2025	☀ PRE	-12.44%	open_in_new
Nov 07, 2024	☀ PRE	-6.75%	open_in_new
Aug 08, 2024	☀ PRE	+7.21%	open_in_new
May 09, 2024	☀ PRE	-5%	open_in_new
Mar 14, 2024	☽ POST	+24.09%	open_in_new
Nov 08, 2023	☀ PRE	-11.93%	open_in_new
Aug 25, 2023	☀ PRE	-8%	open_in_new
May 08, 2023	☀ PRE	-2.75%	open_in_new
Mar 09, 2023	☀ PRE	-22.23%	open_in_new
Nov 03, 2022	☽ POST	-4.91%	open_in_new
Aug 04, 2022	☽ POST	-3.66%	open_in_new
May 09, 2022	☽ POST	+24.06%	open_in_new
Mar 01, 2022	☽ POST	+13.95%	open_in_new
Nov 04, 2021	☀ PRE	-8.98%	open_in_new
Aug 05, 2021	☀ PRE	+15.73%	open_in_new
May 10, 2021	☀ PRE	-7.05%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±12.69%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 3 →

Funds holding

$1419670

Total value held

Buying

2 added · 1 reduced

Ameriprise Financial Inc

$713823 NEW BUY

Bank Of New York Mellon Corp

$705830 -4.87%

Amalgamated Financial Corp.

$17 NEW BUY

SEC Filing Types

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
4	20260810	open_in_new SEC.gov
10-Q	20260805	open_in_new SEC.gov
8-K	20260805	open_in_new SEC.gov
S-8	20260805	open_in_new SEC.gov
4	20260701	open_in_new SEC.gov
8-K	20260630	open_in_new SEC.gov
144	20260629	open_in_new SEC.gov
4	20260622	open_in_new SEC.gov
4	20260622	open_in_new SEC.gov
4	20260622	open_in_new SEC.gov

Frequently asked about AKBA earnings

When does Akebia Therapeutics, Inc. report earnings next? expand_more

Akebia Therapeutics, Inc. (AKBA)'s next earnings date is approximate for 2026-11-06. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does AKBA stock move after earnings? expand_more

Over 22 reports, AKBA has moved an average of ±12.69% the session after earnings, closing higher 31.8% of the time.

What was AKBA's biggest post-earnings move? expand_more

AKBA's largest post-earnings gain on record was +24.09% on Mar 14, 2024, and its largest decline was -26.05% on Aug 05, 2026.

Where can I find Akebia Therapeutics, Inc.'s SEC filings? expand_more

All of Akebia Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.